share_log

Guggenheim Maintains Buy on Medpace Hldgs, Lowers Price Target to $432

Benzinga ·  Jul 24 19:46  · Ratings

Guggenheim analyst Sandy Draper maintains Medpace Hldgs (NASDAQ:MEDP) with a Buy and lowers the price target from $464 to $432.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment